ing expense associated with the debt discount recognized in connection with the senior secured promissory notes as compared to $0 in 2011. Interest expense for the three months ended March 31, 2012 was approximately $243,000 as compared to approximately $91,000 in the prior year. The increase in reported interest expense of approximately $152,000 includes approximately $150,000 in coupon interest related to the $5M convertible promissory note, the convertible note with related party and the convertible debt related to the acquisition.Use of non-GAAP financial measuresManagement has disclosed adjusted financial measurements in this press announcement that present financial information that is not in accordance with GAAP. These measurements are not a substitute for GAAP measurements, although Company management uses these measurements as aids in monitoring the Company's on-going financial performance from quarter-to-quarter and year-to-year on a regular basis, and for benchmarking against other medical technology companies.
*Adjusted EBITDA is Earnings before interest, taxes, depreciation, amortization and share- based compensation. For a reconciliation of this non-GAAP financial measure to the most directly comparable financial measure, see accompanying table to this release. Adjusted financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. Investors should consider adjusted measures in addition to, and not as a substitute for, or superior to, financial performance measures prepared in accordance with GAAP.
Earnings CallMiMedx management will host a live broadcast of its first quarter of 2012 conference call on Wednesday, May 2, 2012, beginning at 10:30 a.m. eastern time. A listen-only simulcast of the MiMedx Group conference call will be available online at the Company's website at www.mimedx.comPage: 1 2 3 4 5 6 7 8 9 Related biology technology :1
. MiMedx Group Announces Temporary Trading Symbol Designation2
. MiMedx Group, Inc. to Present at Noble Financial Sixth Annual Equity Conference3
. MiMedx Group, Inc. Announces Release Date For Third Quarter Results4
. MiMedx Group, Inc. to Present at the 13th Annual Needham Growth Conference5
. MiMedx to Attend American Academy of Orthopedic Surgeons Annual Meeting6
. MiMedx Announces Launch of AmnioFix™7
. MiMedx Group, Inc. to Present at the 10th Annual Needham Healthcare Conference8
. MiMedx Group Announces 2010 Results9
. MiMedx Group Announces First Quarter 2011 Results10
. MiMedx Group, Inc. to Present at the Noble Financial Capital Markets Seventh Annual Equity Conference11
. MiMedx Group Completes $5,000,000 Private Placement